Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS - Trial NCT05902117
Access comprehensive clinical trial information for NCT05902117 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital NOVO and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 270 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hôpital NOVO
Timeline & Enrollment
N/A
Jun 28, 2023
Sep 01, 2024
Primary Outcome
Demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old (sensitivity/specificity),Demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old (negative predictive value)
Summary
The aim of this study is to demonstrate that a combined troponin and copeptin assay can
 exclude non-ST+ ACS in patients with chest pain less than 6 hours old.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05902117
Non-Device Trial